was lower in AA than in EA children (P = 0.0012), and there was a slight sex-related difference (FE L, 24% (10%) vs 29% (10%) in boys vs girls; P = 0.04). Extra-hepatic insulin clearance did not differ with ethnicity (27 (12), 21 (12) and 24 (28) mL/kg/min for AA, HA and EA children, respectively; P > 0.05).
| INTRODUCTION
Diabetes incidence is 2.4-fold higher in African American (AA) women, 1 1.5-fold higher in AA men 1 and 1.6-fold higher in Hispanic American (HA) individuals 2 compared to Caucasian counterparts. The causes of these differences among ethnic groups remain unknown. One possible mechanism could relate to differences in insulin degradation rates. Adult AA women have two-thirds lower hepatic insulin first-pass extraction clearance than their European American (EA) counterparts, 3 although no difference was found concerning the extra-hepatic component. The impairment of hepatic insulin clearance in AA individuals, together with a higher insulin secretion rate, could be related to the increased peripheral hyperinsulinaemia in AA compared to EA individuals. 3 Higher insulin in the blood is associated with insulin resistance. 4, 5 Therefore, it is possible that long-term hyperinsulinaemia contributes to insulin resistance in AA individuals. [6] [7] [8] Concerning HA individuals, their hepatic insulin clearance seems to be more similar to that of EA individuals; thus, its relationship with hyperinsulinaemia needs to be determined. In general, whether persistent hyperinsulinaemia can actually cause type 2 diabetes remains controversial, as the multiple interactions between glucose and insulin make it difficult to understand causality. Recently, it has been shown in animal models that moderate reductions in insulin levels can protect against progressive weight gain, insulin resistance and hyperglycaemia. 9 Persistent hyperinsulinaemia could lead to type 2 diabetes through insulin resistance, as compensatory mechanisms of hypersecretion. However, in the long term, beta-cells could become unable to compensate for insulin resistance through secretion, leading then to hyperglycaemia.
The question arises as to the explanation for lower insulin clearance in AA individuals, and less so in the HA ones. Lifestyle among ethnic groups varies, including differences in diet, sleep and smoking habits, alcohol consumption and exercise. Therefore, lifestyle alone could be responsible for the lower rates of hepatic insulin degradation previously observed in AAs. However, it is also possible that differences in insulin clearance among ethnic groups could be related to genetic or epigenetic causes. 7 One might expect that, while genetic or epigenetic factors would come into play throughout life, most lifestyle effects per se might be less evident in younger individuals, plausibly because they take a longer time to build up. Thus, we considered it of interest to ask whether ethnic differences in insulin clearance could be observed in young children before most effects of lifestyle play a major role. If the difference in insulin clearance rates found in adults has been present since childhood, this would suggest that genetic factors are, at least, not to be excluded. In this report we examine insulin clearance rates, hepatic vs extra-hepatic, to determine whether the differences previously seen between EA and AA individuals, and possibly also HA individuals, can be detected in children.
It has been problematic to differentiate between hepatic and extra-hepatic clearance mechanisms in sizeable groups, as traditional methods of measuring clearance do not yield such information. Using a recently introduced modelling approach that employs insulin and C-peptide data during the frequently-sampled intravenous glucose tolerance test (FSIGT), we are able to estimate hepatic vs extrahepatic insulin clearance rates. 10 In the present work, we have applied this novel method to 7-to 13-year-old EA, AA and HA children of both sexes. The results reveal that hepatic first-pass clearance per se is markedly lower in AA than in EA children. This difference suggests that the lesser rate of hepatic degradation appears before most lifestyle factors have had a major effect and, thus, genetic/epigenetic characteristics could be contributors.
| MATERIALS AND METHODS

| Clinical study
The participants in this study have been described previously. 11 These included 203 children without major illness or medical conditions, of both sexes, between the age of 7 and 13 years, and with a minimum body weight (BW) of 20 kg. These data were part of a cross-sectional cohort study assessing population differences in metabolic phenotypes. 11 Only participants with complete data for glucose, insulin and C-peptide throughout the FSIGT were included in the analysis. Children were classified according to parental report as EA (n = 88), HA (n = 60) or AA (n = 55). Of these, 38% of EAs, 65% of HAs and 33% 
| Frequently-sampled intravenous glucose tolerance test
Insulin sensitivity, insulin secretion and insulin clearance were determined from results of the FSIGT, following a previously described protocol. 6 Two blood samples were collected at baseline. At t = 0, a bolus of glucose (50% dextrose, 300 mg/kg) was injected intravenously. mean intra-assay CV was 3.49%; and mean inter-assay CV was 5.57%.
C-peptide from all FSIGT samples was assayed in duplicate 25 μL aliquots with double-antibody radioimmunoassay reagents (Diagnostic Products, Los Angeles, California). Assay sensitivity was 0.318 ng/mL; mean intra-assay CV was 3.57%; and mean inter-assay CV was 5.59%.
| Calculation of hepatic and extra-hepatic insulin clearance
C-peptide and insulin secretion are assumed to be equimolar. The insulin secretion rate (ISR) was calculated using C-peptide deconvolution, with a two-compartment representation and assumed kinetic parameters. 12 Knowing the ISR, both hepatic and extra-hepatic insulin clearance rates were calculated for each individual using a recently published modelling method ( Figure 1 ). 10 In this approach, delivery of insulin to the liver at any time is assumed to be the sum of the current ISR plus the rate of insulin returning to the liver from the bloodstream, which is equal to the hepatic plasma flow rate times the plasma insulin 
| Parameter estimation and statistical analysis
Parameters were estimated using a nonlinear least squares algorithm (lsqnonlin in Matlab, version R2017a). For each participant, the preferred model (linear or saturable) was chosen using the Akaike Information Criterion. 13 Agreement between modelled and measured insulin concentrations was quantified using the weighted residual square sum. 
| RESULTS
The study group comprised 43% EA, 30% HA and 27% AA children.
Anthropometrics, basal plasma concentrations and area under the curve (AUC) for the 203 participants are shown in Table 1 , divided according to ethnicity (see File S1 for further details and the few sexrelated differences). Insulin sensitivity (S I ) and acute insulin response (AIR g ) from the FSIGT are also summarized in Table 1 ; more information on these parameters can be obtained from a previous publication. 11 Few children in the study were obese (EA, 6%; HA, 15%; AA, 7%) according to BMI percentile (obtained from CDC charts representative at the time of data collection).
Mean measured plasma glucose, insulin, C-peptide concentrations and the calculated ISR are shown in Figure 2 , separated according to ethnicity.
| Modelling results
The model we used 10 allowed adequate description of plasma insulin concentrations in all groups, with mean (SD) normalized root square error equalling 12% (5%) in each ethnicity (see average weighted residuals online in File S1). Figure 3A ,B shows average hepatic and extra-hepatic insulin clearance contribution for the three ethnicities.
Hepatic insulin clearance differed with ethnicity, being lower in AA not extra-hepatic, insulin clearance is two thirds lower in AA than in EA non-diabetic adult women. 3 This showed that, in AA women, there is a relationship between decreased hepatic insulin clearance and hyperinsulinaemia. However, the causality of these changes remains to be explored. It is not known whether hypersecretion precedes changes in clearance and the resulting hyperinsulinaemia leads to clearance impairment, or whether lower clearance is an early change leading to hyperinsulinaemia and insulin resistance, followed by compensatory increases in insulin secretion.
Our previous results 3 showed that reduced hepatic clearance in AA individuals concerns adults for whom we can assume a certain lifestyle is already established. Lifestyle-related factors vary and include sleep habits, obesity, smoking status, alcohol consumption, diet and physical exercise. As these factors could differ between AA and EA individuals, 16 In the second part of the test, that is, after exogenous insulin, the occurence of insulinaemia does not differ between AA and EA children, while it is higher in HA children than in EA and AA children, which is confirmed by the higher correspondent ISR (Table 1 Fasting plasma insulin is higher in HA children than in the AA and EA ones (Table 1) . Historically, hyperinsulinaemia has been associated with insulin resistance. 20 Basal insulin increases with level of obesity, suggesting that insulin degradation might decline accordingly. 21 In the present study (Table 1) , HA children show higher basal secretion, with basal ISR and C-peptide values greater than those for both EAs and AAs, and with AIRg values higher for HAs than for EAs. Concerning a possible association between insulin resistance and basal hyperinsulinaemia in HA children, it is unlikely in this study, as S I is slightly lower in HA than in EA children (P = 0.04) ( Table 1 ). In fact, obese children tended to be less insulin sensitive, 22 and even if HA children had the highest obesity rates (see Results), the S I impairment is lost when adjusting for percentage of body fat (Table 1 ).
In the actual cohort, the saturable model 10 was not chosen for any subject, based on the Akaike Information Criterion, showing that linearity of insulin kinetics was sufficient in all children. One could argue that the impairment of hepatic insulin extraction in AA children could be explained by the saturation of insulin uptake at higher insulin concentrations, which, potentially, might remain undetected in the current analysis. Saturation of insulin clearance might play a role, although not necessarily, at insulin levels exceeding 300 μU/mL. 23 Insulin concentrations are lower than 300 μU mL in 93% of participants ( Figure 2A) ; therefore, the linearity option seems to have been reasonably applied here. 24, 25 However, other former results in children were mixed; no difference in hepatic clearance was found in overweight HA young girls, compared to their AA counterparts, 26 while, in children of normal weight, hepatic extraction was lower in AAs compared with HAs. 26 In the present study, only a relatively small portion of the total number of participants was obese according to BMI percentile. Compared to other studies, 27 the analysed cohort in this one is uniquely larger, and comprises children of a wider age range who underwent FSIGT, including both male and female participants; sex was not considered in the work by Goran et al. 27 and no information about it was included. Moreover, to the best of our knowledge, hepatic and extrahepatic components of insulin clearance in young children of different ethnicities are dissected here for the first time, as the result of a new mathematical modeling approach. 10 The present data support the conclusion that, in a sizable cohort, hepatic, but not extra-hepatic, insulin clearance is lower in AA children between 7 and 13 years of age.
Lower hepatic insulin clearance in AA children could corroborate the hypothesis that hepatic insulin clearance might be, in part, genetically/epigenetically inherited. To further investigate this hypothesis, the partial correlation analysis was applied to insulin clearance components and genetic admixture scores (African, European and Amerindian). 11 We found that FE L is positively correlated with European admixture (r = 0.26; P < 0.001) and is negatively correlated with African admixture (r = −0.24; P < 0.001), while there is no relationship between admixtures and CL P . We also assessed whether there was a relationship between FE L and total dietary intake or diet composition, as these factors could differ among ethnic groups, 28 did not decrease with age in children between 7 and 13 years of age.
Although this age range is quite narrow, if lifestyle factors only were involved in the impairment, it should be more evident in the older children, which was not the case. Therefore, it is possible that the few lifestyle differences among children could potentially exacerbate expression of genetic ethnic differences in terms of metabolic outcomes, such as insulin clearance impairment. Further studies are needed to specifically investigate the contribution of diet to insulin clearance.
The expression of enzymes associated with hepatic insulin degradation could be reduced in AA individuals, and perhaps also in HAs.
Liver insulin degradation begins when insulin is bound by its receptor and the receptor-bound complex is internalized into the endosomes through endocytosis; later, the endosome acidifies and insulin is dissociated from the receptor within the vesicle. 29 Historically, the insulin degrading enzyme (IDE) is thought to be responsible for the postbinding insulin degradation process that precedes acidification. 29 Recently, enzyme CEACAM1 has been shown to promote the rate of uptake of the insulin-receptor complex. 30 33 and might be responsible for impaired hepatic insulin clearance.
In conclusion, hepatic and extra-hepatic insulin clearance rates are both estimated for the first time in young children of different ethnicities in this work, revealing lower hepatic insulin clearance in AA compared to EA children. Because of the young age of participants, this difference might be connected also to genetic heritability, rather than to lifestyle only. Further genetic studies are needed for confirmation, and to clarify the molecular mechanisms that regulate insulin clearance.
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